Join to access to all OVN content. Join for Free
Positive Mindset = Positive Outcomes
Positive mindset overcoming negativity bias mindfulness techniques mindset-driven recovery positive habits

Positive Mindset = Positive Outcomes


Share This Article


Summary

In this episode, Don Sandel from Go Positive joins Tom Caravela to explore the power of a positive mindset. They delve into the science behind positivity, introducing the DOSE acronym and discussing the effects of overcoming negativity bias. Don shares techniques for fostering positivity through relationships, self-talk, and mindfulness. The conversation includes practical tips on meditation, choosing happiness, and using technology and exercise to build positive habits. They emphasize the importance of accountability and a supportive social environment. The episode wraps up with inspiring stories of mindset-driven recovery and a note of gratitude.

This weeks MSL Talk podcast guest is Don Sandel, the Founder, speaker, and facilitator at GoPositiv and best-selling author and performance coach who shares research-based solutions for adopting a positive mindset which leads to positive outcomes.

Don shares…

👉 What led him to write his book “Positive Mindshift”
👉 What is most important for people when it comes to mindset
👉 How people can break the habit of negativity bias
👉 What ways we can shift our thoughts and retrain our brain
👉 What kind of daily habits and mindset techniques we can adopt each day

Click for Source
Positive mindset, overcoming negativity bias, mindfulness techniques, mindset-driven recovery, positive habits

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Things will be HARD…but YOU can do hard things!
Partner Avatar MSL Talk: Tom Caravela

Things will be HARD…but YOU can do hard things!

Article
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
OVN Avatar S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny

Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale

Article
Sponsorship of oncology clinical trials in the United States according to age of eligibility
OVN Avatar Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois

Sponsorship of oncology clinical trials in the United States according to age of eligibility

Article
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
OVN Avatar Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li

Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?

Article
Finding the Right Drug at the Right Dose the First Time: Has the Era of Personalized Formularies Finally Arrived?
OVN Avatar Karen Geary

Finding the Right Drug at the Right Dose the First Time: Has the Era of Personalized Formularies Finally Arrived?

Article
Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology
OVN Avatar J. Remon, R. García-Campelo, E. de Álava, R. Vera, J. L. Rodríguez-Peralto, Á. Rodríguez-Lescure, B. Bellosillo, P. Garrido, F. Rojo & R. Álvarez-Alegret

Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

Explore OVN